69 FR 200 pg. 61357 - Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Small Molecule Inhibitors of Botulinum Toxin
Type: NOTICEVolume: 69Number: 200Page: 61357
FR document: [FR Doc. 04-23231 Filed 10-15-04; 8:45 am]
Agency: Defense Department
Sub Agency: Department of the Army
Official PDF Version: PDF Version
DEPARTMENT OF DEFENSE
Department of the Army
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Small Molecule Inhibitors of Botulinum Toxin
AGENCY:
Department of the Army, DoD.
ACTION:
Notice.
SUMMARY:
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in U.S. Provisional Patent Application Serial No. 60/501,243 entitled "Small Molecule Inhibitors of Botulinum Toxin," filed September 8, 2003. The United States government, as represented by the Secretary of the Army, has rights in this invention.
ADDRESSES:
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA-Z, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 04-23231 Filed 10-15-04; 8:45 am]
BILLING CODE 3710-08-M